for medical use
of Klimadinonâ medicine
the Trade name
the International unlicensed name
Is not present
the Dosage form
of the Tablet, coated
One tablet contains
active agent: Tsimitsifug of rhizomes of extract of dry 20.00 mg (contains 2.8 mg of a tsimitsifuga of rhizomes of extract native (5-10:1, extractant ethanol of 58% about/about) and lactoses of monohydrate of 17.2 mg)
excipients: hydrophosphate calcium a dihydrate, potato starch, magnesium stearate, talc, the titan dioxide (E 171), gland (III) oxide yellow (E 172), gland (III) oxide red (E 172), the macrogoal 6000, eudragit RL 30D
of the Tablet, coated, round shape, with a biconvex and smooth surface, terracotta color.
The pharmacotherapeutic group
Other drugs for treatment of gynecologic diseases
the ATX G02CX Code
Klimadinon® properties has estrogenopodobny effect, shows sedative properties, makes therapeutic impact on the autonomic nervous system. Use of drug promotes: to elimination of psychoemotional and vegeto-vascular disturbances, easing or total disappearance of the symptoms of an indisposition arising during the pre-climacteric and climacteric periods. The therapeutic effect of Klimadinona® occurs gradually and is shown approximately in 2 weeks of treatment.
– vegeto-vascular and psychoemotional disorders in pre-, meno- and a postmenopause (inflows, the increased perspiration, a sleep disorder, the increased nervous irritability, changes of mood, apathy)
the Route of administration and doses
Inside on one tablet twice a day (in the morning and in the evening), with a small amount of liquid and, whenever possible, at the same time day, without chewing also not rassasyvy.
A course of treatment – 3 months, if necessary perhaps more prolonged use. Without consultation of the doctor it is not necessary to take the drug
more than 6 months.
– allergic reactions (itching, rash, a face edema, peripheral hypostases). Frequency is not known
– disturbance of work of digestive tract (dispepsichesky disorders, diarrhea). Frequency is not known
Administration of drugs containing a tsimitsifuga, can be followed by hepatic toxicity (including hepatitis, jaundice, abnormal liver functions). Frequency is not known.
At emergence of side effects intake of medicine it is necessary to stop and see a doctor.
– individual hypersensitivity to drug components
– patients about estrogen – dependent tumors
– the period of pregnancy and a lactation
– an inborn lactose intolerance, hereditary intolerance of fructose, a glucose/galactose sprue
At combined use strengthening of effect of estrogen is possible.
Patients with diabetes
One tablet contains 0.01 grain units (GU).
The concomitant use of estrogen should be carried out under observation of the doctor as Klimadinon® can strengthen their action.
The patients accepting female sex hormones (are oestrogenic), and also patients who received medical treatment or pass a breast cancer or other hormonal and dependent tumors, before use of drug it is necessary to consult the doctor.
In case of irregular or renewable menstrual bleeding it is necessary to consult with the doctor.
Lactose is a part of medicine.
To the patients having in the anamnesis of a disease of a liver, it is necessary to take the drug Klimadinon® after consultation with the doctor. At emergence of such signs, as: jaundice, urine of dark color, pain in an upper part of an abdominal cavity, nausea, vomiting, loss of appetite, fatigue, it is necessary to stop administration of drug and to see a doctor.
Features of influence of medicine on ability to run the vehicle or potentially dangerous mechanisms
Drug in the recommended doses does not affect ability to run the vehicle or potentially dangerous mechanisms.
Symptoms: strengthening of side effects of drug.
Treatment: symptomatic therapy.
A form of release and packing
On 15 tablets coated in blister strip packaging from aluminum foil and a film from PVC, PVDH.
On the 4th blister strip packaging together with the instruction for medical use in the state and Russian languages place in a pack from cardboard.
To Store storage conditions in the dry, protected from light place, at a temperature not above 30 °C.
To store out of children’s reach!
not to apply a period of storage after an expiration date.
the Producer Bionorika XIE, D-92308 of Noymarkt / Germany
the Owner of the registration certificate
Bionorika XIE, D-92308 of Noymarkt / Germany
the Address of the organization accepting claims for territories of RK from consumers concerning quality of a product:
Representation Bionorika XIE/BIONORICA SE in RK
of Almaty, Central post office, p.o. box No. 200, ph. 250-93-99